173 related articles for article (PubMed ID: 36091128)
21. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
22. A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma.
Ju H; Wei D; Wu Y; Liu Y; Ding Q; Rui M; Fan Z; Yao Y; Hu J; Ren G
MedComm (2020); 2023 Aug; 4(4):e312. PubMed ID: 37492783
[TBL] [Abstract][Full Text] [Related]
23. Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma.
Zhang B; Qi L; Wang X; Xu J; Liu Y; Mu L; Wang X; Bai L; Huang J
Cancer Commun (Lond); 2020 Dec; 40(12):711-720. PubMed ID: 33314747
[TBL] [Abstract][Full Text] [Related]
24. Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
Lan C; Shen J; Wang Y; Li J; Liu Z; He M; Cao X; Ling J; Huang J; Zheng M; Zou G; Yan H; Liu Q; Yang F; Wei W; Deng Y; Xiong Y; Huang X
J Clin Oncol; 2020 Dec; 38(34):4095-4106. PubMed ID: 33052760
[TBL] [Abstract][Full Text] [Related]
25. Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination.
Ju S; Zhou C; Hu J; Wang Y; Wang C; Liu J; Yang C; Huang S; Li T; Chen Y; Bai Y; Yao W; Xiong B
BMC Cancer; 2022 Mar; 22(1):335. PubMed ID: 35346114
[TBL] [Abstract][Full Text] [Related]
26. Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial.
Zhou C; Chen G; Huang Y; Zhou J; Lin L; Feng J; Wang Z; Shu Y; Shi J; Hu Y; Wang Q; Cheng Y; Wu F; Chen J; Lin X; Wang Y; Huang J; Cui J; Cao L; Liu Y; Zhang Y; Pan Y; Zhao J; Wang L; Chang J; Chen Q; Ren X; Zhang W; Fan Y; He Z; Fang J; Gu K; Dong X; Zhang T; Shi W; Zou J;
Lancet Respir Med; 2021 Mar; 9(3):305-314. PubMed ID: 33347829
[TBL] [Abstract][Full Text] [Related]
27. Rechallenge of camrelizumab in non-small-cell lung cancer patients treated previously with camrelizumab and microwave ablation.
Wei Z; Yang X; Ye X
J Cancer Res Ther; 2020 Sep; 16(5):1191-1195. PubMed ID: 33004770
[TBL] [Abstract][Full Text] [Related]
28. Efficacy, safety and prognostic factors of camrelizumab plus carboplatin and pemetrexed chemotherapy in advanced lung adenocarcinoma patients.
Lv J; Zhang W; Deng R; Chen Y; Liu M; Zhang Z; Wang Q; He Y; Liu Y; Wang F; Lv Z; Zhou H; Li C; Zhang T; Fu Y; Zhao X; Bao Q; Miao Y; Wang L; Huang M; Zhang C
J Clin Pharm Ther; 2022 Aug; 47(8):1257-1263. PubMed ID: 35397125
[TBL] [Abstract][Full Text] [Related]
29. Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non-small cell lung cancer.
Das SK; Huang YY; Li B; Yu XX; Xiao RH; Yang HF
Oncol Lett; 2020 Jan; 19(1):1031-1041. PubMed ID: 31885721
[TBL] [Abstract][Full Text] [Related]
30. Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study.
Zhou H; Wang Y; Lin Y; Cai W; Li X; He X
Front Oncol; 2021; 11():774445. PubMed ID: 34900725
[TBL] [Abstract][Full Text] [Related]
31. The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study.
Wang D; Yang X; Long J; Lin J; Mao J; Xie F; Wang Y; Wang Y; Xun Z; Bai Y; Yang X; Guan M; Pan J; Seery S; Sang X; Zhao H
Front Oncol; 2021; 11():646979. PubMed ID: 33912461
[TBL] [Abstract][Full Text] [Related]
32. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
[No Abstract] [Full Text] [Related]
33. Advanced non small cell lung cancer: response to microwave ablation and EGFR Status.
Wei Z; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Meng M; Ni Y
Eur Radiol; 2017 Apr; 27(4):1685-1694. PubMed ID: 27436020
[TBL] [Abstract][Full Text] [Related]
34. Microwave ablation or plus monochemotherapy in elderly advanced non-small-cell lung cancer patients.
Wei Z; Li Q; Ye X; Yang X; Huang G; Li W; Wang J; Han X
Minim Invasive Ther Allied Technol; 2021 Apr; 30(2):106-114. PubMed ID: 31621453
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of microwave ablation in the treatment of patients with oligometastatic non-small-cell lung cancer: a retrospective study.
Wei Z; Ye X; Yang X; Huang G; Li W; Han X; Wang J; Meng M; Ni Y; Li Q
Int J Hyperthermia; 2019; 36(1):827-834. PubMed ID: 31450998
[No Abstract] [Full Text] [Related]
36. Computerized tomography-Guided Microwave Ablation of Patients with Stage I Non-small Cell Lung Cancers: A Single-Institution Retrospective Study.
Nance M; Khazi Z; Kaifi J; Avella D; Alnijoumi M; Davis R; Bhat A
J Clin Imaging Sci; 2021; 11():7. PubMed ID: 33654576
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial.
Liu J; Liu Q; Li Y; Li Q; Su F; Yao H; Su S; Wang Q; Jin L; Wang Y; Lau WY; Jiang Z; Song E
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32448804
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of camrelizumab in combination with trastuzumab and chemotherapy as the first-line treatment for patients with HER2-positive advanced gastric cancer.
Xu M; Meng X; Lu Y; Wang F
J Gastrointest Oncol; 2022 Apr; 13(2):548-558. PubMed ID: 35557572
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer in patients with comorbid idiopathic pulmonary fibrosis.
Peng J; Bie Z; Li Y; Guo R; Li X
Eur Radiol; 2023 Dec; ():. PubMed ID: 38114848
[TBL] [Abstract][Full Text] [Related]
40. Drug-Eluting Bead Bronchial Arterial Chemoembolization With and Without Microwave Ablation for the Treatment of Advanced and Standard Treatment-Refractory/Ineligible Non-Small Cell Lung Cancer: A Comparative Study.
Xu S; Bie ZX; Li YM; Li B; Kong FL; Peng JZ; Li XG
Front Oncol; 2022; 12():851830. PubMed ID: 35371971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
